| Title |
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial
|
|---|---|
| Published in |
Psychopharmacology, September 2006
|
| DOI | 10.1007/s00213-006-0516-y |
| Pubmed ID | |
| Authors |
F. Joseph McClernon, F. Berry Hiott, Eric C. Westman, Jed E. Rose, Edward D. Levin |
| Abstract |
Despite established links between nicotine dependence and depression, little research has examined the effects of nicotine on depression symptoms. |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 41% |
| United Kingdom | 2 | 6% |
| Canada | 1 | 3% |
| Unknown | 16 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 29 | 91% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
| Scientists | 1 | 3% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Unknown | 95 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 20 | 21% |
| Researcher | 17 | 18% |
| Student > Bachelor | 10 | 10% |
| Student > Master | 9 | 9% |
| Professor > Associate Professor | 5 | 5% |
| Other | 18 | 19% |
| Unknown | 18 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 24 | 25% |
| Medicine and Dentistry | 12 | 12% |
| Neuroscience | 9 | 9% |
| Agricultural and Biological Sciences | 7 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 11 | 11% |
| Unknown | 31 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2023.
All research outputs
#1,346,552
of 25,516,314 outputs
Outputs from Psychopharmacology
#327
of 5,339 outputs
Outputs of similar age
#2,273
of 87,330 outputs
Outputs of similar age from Psychopharmacology
#7
of 50 outputs
Altmetric has tracked 25,516,314 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,339 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 87,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.